MAPT and myeloid sarcoma: Significantly higher total tau concentration was measured in MS patients with higher LL in brain MRI (≥9 versus <9 lesions; 168.33 pg/mL, IQR 111.67–222.32, and 73.33 pg/mL, IQR 32.13–139.29, p = 0.021).